- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CD27, also known as TNF receptor superfamily member 7 (TNFRSF7), is a costimulatory receptor expressed on T lymphocytes, memory B cells, and subsets of natural killer cells, where it regulates immune activation, survival, and differentiation. CD27 Antibody / Immune Checkpoint Pathway Antibody (clone LPFS2/8838R) is uniquely positioned for studying CD27 within the context of immune regulation and checkpoint-related signaling pathways, enabling investigation of how CD27 contributes to the balance between immune activation and control. CD27 antibody reagents are increasingly used in research focused on immune checkpoint biology and immunotherapeutic strategies.
CD27 antibody, also referred to as TNFRSF7 antibody or CD27 immune checkpoint antibody in the literature, functions through interaction with CD70 to regulate T cell expansion, cytokine production, and survival. While CD27 is traditionally categorized as a costimulatory receptor, its activity intersects with broader immune regulatory networks that influence immune response magnitude and duration. This positions CD27 within a functional landscape that overlaps with immune checkpoint pathways and makes it relevant for studies of immune modulation.
CD27 Antibody / Immune Checkpoint Pathway Antibody (clone LPFS2/8838R) supports analysis of CD27 expression in contexts where immune regulation is critical, including tumor immunity, chronic infection, and inflammatory conditions. Detection of CD27 provides insight into signaling pathways that influence immune cell activation thresholds and functional responses, contributing to a more complete understanding of immune regulatory mechanisms.
In tumor microenvironments, CD27 expression on lymphocytes reflects active engagement of immune cells and may be associated with functional subsets that contribute to anti-tumor immunity. The CD27-CD70 axis has been explored as a target for immunotherapy, further emphasizing the importance of accurately detecting CD27 in studies of immune regulation and therapeutic response. CD27 expression can therefore serve as an indicator of immune activity within regulatory signaling networks.
In addition to tumor contexts, CD27 plays a role in regulating immune responses during infection and inflammation, where controlled activation is necessary to balance effective immunity with prevention of excessive tissue damage. Antibodies that enable precise detection of CD27 support studies of these regulatory processes and help define how immune signaling pathways are coordinated across different biological conditions.
The recombinant rabbit monoclonal clone LPFS2/8838R antibody is designed to provide consistent and reproducible detection of CD27, supporting reliable analysis of immune regulatory pathways and checkpoint-related signaling. Its performance enables detailed investigation of CD27 expression in both physiological and disease contexts.
Overall, CD27 Antibody / Immune Checkpoint Pathway Antibody (clone LPFS2/8838R) provides robust detection of CD27 for studies focused on immune regulation, checkpoint-related signaling, and the functional modulation of immune responses in health and disease.
This antibody is part of a broader CD27 antibody collection designed to support diverse immunological research applications.
Optimal dilution of the CD27 Antibody / Immune Checkpoint Pathway Antibody should be determined by the researcher.
Recombinant human full-length protein was used as the immunogen for the CD27 antibody.
Aliquot the CD27 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
TNFRSF7 antibody, CD27 immune checkpoint antibody, CD27 immunotherapy target antibody, CD27 immune regulation antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.